Informations générales (source: ClinicalTrials.gov)
Intestinal Microbiota and Vitamin K Levels in PXE Patients (IMPROVE Study) (IMPROVE)
Interventional
N/A
University Hospital, Angers (Voir sur ClinicalTrials)
janvier 2019
janvier 2020
29 juin 2024
This study aims to demonstrate a potential association between gut microbiota
composition, plasma levels of various forms of vitamin K, and severity of clinical
manifestations of Pseudoxanthoma Elasticum (PXE).
Etablissements
| Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
|---|---|---|---|---|---|
| Biofortis Mérieux NutriSciences - 44800 - Saint-Herblain - Pays De La Loire - France | Contact (sur clinicalTrials) | ||||
| Department of Dermatology, University Hospital of Angers - 49933 - Angers - Pays De Loire - France | Ludovic Martin, MD, PhD | Contact (sur clinicalTrials) | |||
Critères
Tous
Inclusion Criteria:
- Patients with phenotypically and genetically (ABCC6) proven PXE
- Aged over 18 years
- Written consent obtained for Angers University Hospital (France) PXE bio-collection
- Patients with phenotypically and genetically (ABCC6) proven PXE
- Aged over 18 years
- Written consent obtained for Angers University Hospital (France) PXE bio-collection
- Patients under the age of 18
- Patients unwilling to participate in the study, or unable to sign the bio-collection
consent form